Charles W Lynde Selected Research

Charles W Lynde Research Topics

Disease

19	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2023 - 08/2010
7	Atopic Dermatitis (Atopic Eczema) 07/2023 - 04/2014
4	Inflammation (Inflammations) 05/2023 - 07/2014
3	Neoplasms (Cancer) 11/2023 - 05/2022
3	Eczema 05/2023 - 01/2021
3	Acne Vulgaris 11/2014 - 01/2003
2	Infections 04/2023 - 05/2022
2	Erythema 01/2023 - 01/2003
2	Mycoses (Diseases, Fungus) 07/2022 - 07/2003
2	Psoriatic Arthritis 05/2022 - 03/2019
2	COVID-19 01/2021 - 01/2021
1	Pruritus (Itching) 11/2023
1	Pain (Aches) 11/2023
1	Dermatitis 11/2023
1	Seborrheic Dermatitis 01/2023
1	Hyperplasia 07/2022
1	Candidiasis (Moniliasis) 07/2022
1	Trichotillomania 03/2022
1	Impetigo (Impetigo Contagiosa) 04/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Contact Dermatitis (Eczema, Contact) 01/2021
1	Ankylosing Spondylitis 03/2019
1	Hidradenitis Suppurativa 06/2018
1	Crohn Disease (Crohn's Disease) 06/2018
1	Ulcerative Colitis 06/2018
1	Rheumatoid Arthritis 06/2018
1	Warts (Wart) 12/2017
1	Skin Neoplasms (Skin Cancer) 05/2015
1	Herpes Zoster 07/2011
1	Onychomycosis (Tinea Unguium) 07/2003
1	Tinea Capitis 07/2003

Drug/Important Bio-Agent (IBA)

4	Adalimumab (Humira)FDA Link 04/2022 - 08/2010
3	dupilumabIBA 07/2023 - 10/2021
3	Interleukin-17 (Interleukin 17)IBA 07/2022 - 07/2014
3	Etanercept (Enbrel)FDA Link 05/2018 - 08/2010
2	CeramidesIBA 08/2023 - 04/2014
2	Immunoglobulin A (IgA)IBA 01/2023 - 01/2019
2	RoflumilastIBA 01/2023 - 01/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 11/2014
2	InterleukinsIBA 03/2019 - 07/2014
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 08/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2023
1	Chemokine CCL17IBA 05/2023
1	Biomarkers (Surrogate Marker)IBA 05/2023
1	Immunoglobulin E (IgE)IBA 05/2023
1	VaccinesIBA 05/2022
1	Prostaglandins AIBA 05/2022
1	Certolizumab Pegol FDA Link 05/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2022
1	abrocitinibIBA 01/2022
1	ozenoxacinIBA 04/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Irritants (Vesicants)IBA 01/2021
1	secukinumabIBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 12/2017
1	Midazolam (Versed)FDA LinkGeneric 12/2017
1	Acitretin FDA Link 11/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	EmollientsIBA 01/2016
1	ixekizumabIBA 01/2016
1	RetinoidsIBA 11/2014
1	ChemokinesIBA 07/2014
1	CytokinesIBA 07/2014
1	Dapsone FDA Link 01/2014
1	gallium arsenide (GaAs)IBA 01/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2011
1	Terbinafine (Lamisil)FDA LinkGeneric 07/2003
1	AllylamineIBA 07/2003
1	Squalene Monooxygenase (Squalene Epoxidase)IBA 07/2003
1	Griseofulvin (Grifulvin V)FDA LinkGeneric 07/2003
1	Erythromycin (Erycette)FDA LinkGeneric 01/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2003
1	erythromycin drug combination benzoyl peroxide FDA LinkGeneric 01/2003
1	GelsIBA 01/2003
1	Benzoyl Peroxide FDA LinkGeneric 01/2003

Therapy/Procedure

12	Therapeutics 11/2023 - 07/2003
2	Phototherapy (Light Therapy) 01/2019 - 08/2012
1	Radiotherapy 11/2023
1	Drug Tapering 01/2022
1	Retreatment 01/2022
1	Personal Protective Equipment 01/2021
1	Biological Therapy 01/2019
1	Secondary Prevention 05/2015